Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q1Scopus Q1KCI Q2
- 저널
- JOURNAL OF GYNECOLOGIC ONCOLOGY34(2) · pp.e39 · 2023
- 피인용
- Web of Science 16Scopus 17KCI 2
- FWCI (Scopus)
- 1.94
- JCR IF
- JCR 2022 3.9
- ISSN
- 2005-0380
저자
- Suh, Dong Hoon제1저자Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea
- 하형인Pusan Natl Univ, Yangsan Hosp, Dept Obstet & Gynecol, Yangsan, South Korea
- Lee, Yeon JeeRes Inst & Hosp, Natl Canc Ctr, Ctr Gynecol Canc, Goyang, South Korea
- Lim, JiwonNatl Canc Ctr, Natl Canc Control Inst, Div Canc Registrat & Surveillance, Goyang, South Korea
- Won, Young-Joo교신저자Natl Canc Ctr, Natl Canc Control Inst, Div Canc Registrat & Surveillance, Goyang, South Korea
- Lim, Myong Cheol교신저자Res Inst & Hosp, Natl Canc Ctr, Ctr Gynecol Canc, Goyang, South Korea
초록
OBJECTIVE: To describe the incidence and survival outcomes of uterine cervical cancer during 1999-2018. METHODS: Patients who were diagnosed with cervical cancer during 1999-2018 were identified in the Korea Central Cancer Registry. Age-standardized incidence rates (ASRs) and annual percent changes (APCs) were calculated. Survival rates by histology, year of diagnosis (1999-2008 vs. 2009-2018), stage, and age at diagnosis were analyzed. RESULTS: The absolute incidence of cervical cancer decreased over 20 years from 4,488 in 1999 to 3,500 in 2018, with an APC of -3.42% (p<0.0001). While ASR of squamous cell carcinoma (SCCA) more than halved from 13.27 per 100,000 in 1999 to 6.16 in 2018 (APC, -4.04%), adenocarcinoma continued to rise (ASR, 1.30 per 100,000 to 1.92; APC, 1.52%; p<0.0001). Patients with adenocarcinoma were younger than those with SCCA (mean, 49.9±12.7 vs. 52.9 ±14.6 years; p<0.0001). Five-year survival rate of cervical cancer patients overall was 78.0%. Adenocarcinoma had poorer survival than SCCA (5-year survival rate, 76.8% vs. 79.8%; p<0.0001). There was no survival difference between patients who were diagnosed between 1999-2008 and 2009-2018. Earlier-stage disease had better survival (5-year survival rate for localized, regional, and distant disease, 90.0% vs. 69.9% vs. 26.5%; p<0.0001). Younger patients aged <50 years had better survival than those aged ≥50 years (87.1% vs. 69.8%; p<0.0001). CONCLUSION: The incidence of SCCA of the uterine cervix declined while adenocarcinoma continued to increase slowly but significantly from 1999 to 2018 in Korea. Adenocarcinoma was diagnosed at a younger age, but had poorer survival outcome than SCCA.
키워드
AdenocarcinomaCarcinoma, Squamous CellIncidenceSurvivalUterine Cervical NeoplasmsSQUAMOUS-CELL CARCINOMAADENOCARCINOMASTATISTICSSURVIVAL
식별자
- Scopus EID
- 2-s2.0-85150000104
- WoS UID
- 000949754300004
- KCI
- ART002938718



로그인
연구물 목록으로